Hepatitis Monthly

Published by: Kowsar

Hepatitis B Seroprevalence and the Relationship Between Being Hepatitis B Vaccinated and Infected with Social Determinants of Health: Manisa, 2014

Hilal Gorgel Kahraman 1 , * , Ozgen Alpay Ozbek 2 , Mestan Emek 3 , Gonca Atasoylu 4 , Ozgur Sekreter 4 and Belgin Unal 5
Authors Information
1 Narlidere Health Directorate, Izmir, Turkey
2 Dokuz Eylul University Medical Faculty, Department of Medical Microbiology, Izmir, Turkey
3 Antalya Public Health Directorate, Antalya, Turkey
4 Manisa Public Health Directorate, Manisa, Turkey
5 Dokuz Eylul University Medical Faculty, Department of Public Health, Izmir, Turkey
Article information
  • Hepatitis Monthly: July 2018, 18 (7); e65395
  • Published Online: June 30, 2018
  • Article Type: Research Article
  • Received: December 21, 2017
  • Revised: May 10, 2018
  • Accepted: May 19, 2018
  • DOI: 10.5812/hepatmon.65395

To Cite: Kahraman H G, Ozbek O A, Emek M, Atasoylu G, Sekreter O, et al. Hepatitis B Seroprevalence and the Relationship Between Being Hepatitis B Vaccinated and Infected with Social Determinants of Health: Manisa, 2014, Hepat Mon. 2018 ;18(7):e65395. doi: 10.5812/hepatmon.65395.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. World Health Organization . Global health sectors strategy on viral hepatitis 2016-2021 towards ending viral hepatitis. Geneva, Switzerland: WHO Document Production Services; 2016. Available from: http://www.who.int/iris/handle/10665/246177.
  • 2. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546-55. doi: 10.1016/S0140-6736(15)61412-X. [PubMed: 26231459].
  • 3. Ott JJ, Horn J, Krause G, Mikolajczyk RT. Time trends of chronic HBV infection over prior decades - A global analysis. J Hepatol. 2017;66(1):48-54. doi: 10.1016/j.jhep.2016.08.013. [PubMed: 27592304].
  • 4. Tozun N, Ozdogan O, Cakaloglu Y, Idilman R, Karasu Z, Akarca U, et al. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clin Microbiol Infect. 2015;21(11):1020-6. doi: 10.1016/j.cmi.2015.06.028. [PubMed: 26163105].
  • 5. Toy M, Onder FO, Wormann T, Bozdayi AM, Schalm SW, Borsboom GJ, et al. Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review. BMC Infect Dis. 2011;11:337. doi: 10.1186/1471-2334-11-337. [PubMed: 22151620]. [PubMed Central: PMC3262158].
  • 6. Ozmert EN. Progress in the national immunization practices in the world and in Turkey. Cocuk Sagligi ve Hastalikari Dergisi. 2008;51(168-75).
  • 7. World Health Organization . WHO-UNICEF estimates of HepB3 coverage. 2017. Available from: http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragehepb3.html.
  • 8. Stuver SO, Boschi-Pinto C, Trichopoulos D. Infection with hepatitis B and C viruses, social class and cancer. IARC Sci Publ. 1997;(138):319-24. [PubMed: 9353672].
  • 9. World Health Organization . Measurement and targets, final report of the task group on measurement and targets, review of social determinants of health and the health divide in the WHO European region. Copenhagen: WHO Regional Office for Europe; 2016. Available from: http://www.euro.who.int/__data/assets/pdf_file/0004/302872/M-and-T-TG-final-report.pdf?ua=1.
  • 10. Boratav K. Class Profiles form Istanbul and Anatolia. 2nd ed. Ankara: Imge Publisher; 2004.
  • 11. Lubrano M. The econometrics of inequality and poverty Lecture 8: Equivalence scales. 2016. Available from: http://www.vcharite.univ-mrs.fr/PP/lubrano/cours/Lecture-8.pdf.
  • 12. Dominguez-Almendros S, Benitez-Parejo N, Gonzalez-Ramirez AR. Logistic regression models. Allergol Immunopathol (Madr). 2011;39(5):295-305. doi: 10.1016/j.aller.2011.05.002. [PubMed: 21820234].
  • 13. Jack AD, Hall AJ, Maine N, Mendy M, Whittle HC. What level of hepatitis B antibody is protective? J Infect Dis. 1999;179(2):489-92. doi: 10.1086/314578. [PubMed: 9878036].
  • 14. Banatvala JE, Van Damme P. Hepatitis B vaccine -- do we need boosters? J Viral Hepat. 2003;10(1):1-6. [PubMed: 12558904].
  • 15. Lu S, Ren J, Li Q, Jiang Z, Chen Y, Xu K, et al. Effects of hepatitis B vaccine boosters on anti-HBs-negative children after primary immunization. Hum Vaccin Immunother. 2017;13(4):903-8. doi: 10.1080/21645515.2016.1260794. [PubMed: 27905821]. [PubMed Central: PMC5404365].
  • 16. Chiara F, Bartolucci GB, Cattai M, Piazza A, Nicolli A, Buja A, et al. Hepatitis B vaccination of adolescents: significance of non-protective antibodies. Vaccine. 2013;32(1):62-8. doi: 10.1016/j.vaccine.2013.10.074. [PubMed: 24188755].
  • 17. Poorolajal J, Hooshmand E. Booster dose vaccination for preventing hepatitis B. Cochrane Database Syst Rev. 2016;(6). CD008256. doi: 10.1002/14651858.CD008256.pub3. [PubMed: 27271960].
  • 18. Buran T, Tosun S, Aksu S, Koroglu G, Eskicioglu F, Kasirga E. The importance of vaccination of child, adolescent and young adult age groups in fighting against HBV Infection. CBU-SBED. 2015;2(1):16-8.
  • 19. Ertekin V, Selimoglu MA, Altinkaynak S. Sero-epidemiology of hepatitis B infection in an urban paediatric population in Turkey. Public Health. 2003;117(1):49-53. [PubMed: 12802905].
  • 20. Tajiri K, Shimizu Y. Unsolved problems and future perspectives of hepatitis B virus vaccination. World J Gastroenterol. 2015;21(23):7074-83. doi: 10.3748/wjg.v21.i23.7074. [PubMed: 26109794]. [PubMed Central: PMC4476869].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments